Platinum Discovery Analysis

Tumour-to-target platform for neoantigen discovery in cancer vaccine development

Identify tumour-specific neoantigens for cancer vaccine development; Analyse patient samples using proteomics and immunopeptidomics; Support clinical trial research with targeted biomarker data; Optimize drug candidate selection through multi-omics integration; Deliver computational analysis of complex biological datasets; Provide end-to-end drug discovery pipeline services for biotech and pharma clients

Named as a key player in neoantigen discovery; Completed contract to discover new targets for cancer immunotherapeutics; Welcomes Prof. Dr. Nicola Ternette as scientific advisor to the board; Serves clients in oncology drug discovery pipeline